Author

Shuto Negishi

Institution: Anjo Kosei Hospital

Observed institutions: Konan Kosei Hospital, Anjo Kosei Hospital, Nagoya University

OpenAlex ID: A5028339951

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma

2024 · Shuto Negishi, James H. Girsch, et al. · Frontiers in Pediatrics · 27

Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response

2022 · Tomoya Hasegawa, Mikako Ito, et al. · International Journal of Molecular Sciences · 27

Molecular hydrogen upregulates heat shock response and collagen biosynthesis, and downregulates cell cycles: meta-analyses of gene expression profiles

2018 · Hiroshi Nishiwaki, Mikako Ito, et al. · Free Radical Research · 22

The Rieske iron-sulfur protein is a primary target of molecular hydrogen

2025 · Shuto Negishi, Mikako Ito, et al. · Redox Biology · 17

Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia

2024 · Yuma Kawamura, Nako Uchibori, et al. · eJHaem · 13

Clinical Benefit of Low-Dose Antithymocyte Globulin-Thymoglobulin as Graft-versus-Host Disease Prophylaxis in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Identical Donors

2023 · Yuki Takeuchi, Kotaro Miyao, et al. · Transplantation and Cellular Therapy · 4

Feasibility of trimethoprim/sulfamethoxazole desensitization therapy in hematological diseases

2022 · Shuto Negishi, Kotaro Miyao, et al. · Clinical and Experimental Medicine · 3

Clinical profile and risk factors of low percent vital capacity after allogeneic hematopoietic stem cell transplantation

2025 · Fumiya Ohara, Kotaro Miyao, et al. · Cytotherapy · 1

Efficacy and Safety of Reduced-Dose Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) in Patients over 80 with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

2023 · Kotaro Miyao, Tomoyoshi Wakayama, et al. · Blood · 1

Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes

2026 · Shuto Negishi, Kotaro Miyao, et al. · Annals of Hematology

Intermediate-dose cytarabine as a safer consolidation strategy for acute myeloid leukemia

2025 · Toshiyasu Sakai, Kotaro Miyao, et al. · International Journal of Hematology

Letermovir Improves the Outcome of Allogenic Stem Cell Transplantation with Anti-Thymocyte Globulin By Reducing Relapse

2023 · Shuto Negishi, Kotaro Miyao, et al. · Blood

MO29-1 The present activity and issues of AYA support team for the patients in AYA generation

2023 · Yuichiro Inagaki, Shuto Negishi, et al. · Annals of Oncology

Three cases of suspected pleuroparenchymal fibroelastosis after allogeneic hematopoietic cell transplantation

2023 · Shiori Morikawa, Nobuaki Fukushima, et al. · BLOOD CELL THERAPY / The official journal of APBMT

Molecular Hydrogen Manages Mitochondrial Proteostatic Stress and Induces Cellular Response

2020 · Tomoya Hasegawa, Mikako Ito, et al. · The FASEB Journal

Works count: 15

Citation count: 115

H-index: 5

I10-index: 5